Status:
RECRUITING
Hong Kong Prostate Cancer Study Group Database
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Prostate cancer (PCa) is ranked 3rd in annual incidence of male cancer and ranked 5th for cancer-related death in men in Hong Kong which accounts for about 9.1 deaths per 100,000 men in 2011. Its inci...
Detailed Description
The prostate gland is a clinically important male accessory sex gland and vital for its production of semen. Prostate cancer (PCa) is ranked 3rd in annual incidence of male cancer and ranked 5th for c...
Eligibility Criteria
Inclusion
- Patient at the age of 18 or above
- Patients with clinical diagnosis of prostate cancer
Exclusion
- Patients diagnosed to have ductal type of prostate cancer
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2040
Estimated Enrollment :
15000 Patients enrolled
Trial Details
Trial ID
NCT03344835
Start Date
January 1 2016
End Date
December 31 2040
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong